EmphyCorp Patents

2009004173 filed February 12, 2009

Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells.

6,689,810 issued February 10, 2004

Title: Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide.

6,623,723 issued September 23, 2003

Method for treating bronchial constriction and bronchospasm.

6,482,856 issued November 19, 2002

Title: Method and composition for treating mammalian disease caused by inflammatory response. Claim: A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediator, which reduces the undesired inflammatory response and is an antioxidant.

5,952,384 issued September 14, 1999

Title: Method and composition for treating mammalian diseases caused by inflammatory response. Claim: A method for treating airway diseases in mammals caused by mammalian cells involved in the inflammatory response (with pyruvate).

5,939,459 issued August 17, 1999

Title: Method and composition for treating mammalian disease caused by inflammatory response. Claim: A method for treating emphysema in mammals caused by mammalian cells involved in the inflammatory response (with pyruvate).

5,798,388 issued August 25, 1998

Title: Method and composition for treating mammalian diseases caused by inflammatory response. Claim: A method for treating asthma in mammals caused by mammalian cells involved in the inflammatory response (with pyruvate).